Skip to main content

Journals in Immunology

Elsevier's Immunology collection equips researchers with valuable insights to address the complexities of the immune system and its role in health and disease, offering original research, insightful analysis, and current theory on diagnosing, managing, and advancing treatments for allergies, asthma, and immunologic disorders.

1-10 of 109 results in All results

Acta Haematologica Polonica

  • ISSN: 0001-5814
As of January 1st, 2018, the journal has transferred to a new publisher, De Gruyter Open. All submissions must be made via the online submission system ScholarOne: https://mc.manuscriptcentral.com/ahp. In case of any technical problems, please contact the Journal Office at: [email protected] journal is aimed at physicians specializing in any combination of disciplines providing interdisciplinary assistance in the fields of oncology, experimental haematology, laboratory haematology, cytometry, coagulation studies, transfusion medicine, and transplantology.Acta Haematologica Polonica publishes original experimental papers, case studies, and review articles. We also publish recommendations and guidelines of specialist teams of Polish and international haematologists and transfusion specialists.Papers published in Acta Haematologica Polonica cover specifically such topics as physiology and pathology in haematology and transfusion, focusing on the following areas: leukocytes, erythrocytes, blood platelets, immunological system, mechanisms of haemostasis, clinical aspects of hyperplastic haematological diseases, new advances in therapy and transplantology. Authors of papers published in Acta Haematologica Polonica are researchers from leading clinical and academic centres. Target readership of the journal includes both medical doctors practicing medicine at research level as well as those working in clinics.Acta Haematologica Polonica is the official journal of the http://www.pthit.plPolish Society of Haematology and Blood Transfusion, and the http://www.ihit.waw.plInstitute of Haematology and Transfusion Medicine, associated with Polish haematology and (blood) transfusion since 1970.Articles submitted to the journal are first classified by Section Editor and then evaluated using the double blind peer review method. Articles in both Polish and English are accepted for publication. In addition to regular issues, the Editorial office prepares special issues associated with key conferences in the field.
Acta Haematologica Polonica

Acta Tropica

  • ISSN: 0001-706X
  • 5 Year impact factor: 2.4
  • Impact factor: 2.1
Acta Tropica is an international journal on infectious diseases that covers public health sciences, medical and veterinary entomology, and biomedical research with particular emphasis on topics relevant to human and animal health.Its scope includes the biology of pathogens and vectors, host-parasite relationships, mechanisms of pathogenicity, clinical disease and chemotherapy. We welcome contributions in basic or applied research in disciplines such as epidemiology, disease ecology, diagnostics, interventions and control, drug and insecticide resistance, mathematical modelling, public health and social sciences, climate change, parasite and vector taxonomy, biology, ecology and behaviour, host and parasite genomics, biochemistry, immunology, and vaccine testing.Contributions may be in the form of original research papers, review articles, short communications, opinion articles, or letters to the Editors.Only manuscripts of high scientific significance and innovation will be considered for publication. Criteria for rejection without review:• Out of scope.• Manuscripts of minimal international relevance, including regional reports and studies of local interest.• Case reports.• Parasite and vector control strategies at very early inconclusive laboratory stages of development. For vector control studies, field validation is required.• Field studies not replicated at least over two years. • Studies dealing with natural products (e.g., plant extracts) not characterized from a chemical point of view.• Ethical issues, including plagiarism, submission of the manuscript to multiple journals, and lack of ethical approval where needed.Important Guidelines for AcceptanceEditors and the Editorial Board of Acta Tropica provide the following guidelines to help authors prepare manuscripts of high quality that can be considered for publication. Maximize your chances of acceptance by making sure your manuscript:• Matches the scientific scope of the journal,• Follows the instructions specified in Acta Tropica guide for authors,• Presents results that significantly advance science including innovative new approaches,• Meets quality standards of presentation and literature citation,• Demonstrates potential health or biomedical impact.The above points are critical for the publication of original papers. Be aware Editors carefully evaluate initial manuscript submissions and only those meeting the above criteria will be forwarded to review. If reviewed favourably and the authors seriously address all concerns, then chances of acceptance are increased. Review and Opinion articles may be invited by the Editors in Chief or submitted by authors responding to a recognized need. Reviews are expected to carefully synthesize and discuss the literature and make recommendations to advance respective scientific fields. Reviews and Opinions submitted by authors without research experience on the topic covered by the manuscript will not be considered. Systematic reviews adhering to PRISMA guidelines and meta-analyses are welcome. For any inquiry about Reviews and Opinions please contact our Special Content Editor, Prof. John Beier.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Acta Tropica

American Journal of Preventive Medicine

  • ISSN: 0749-3797
  • 5 Year impact factor: 4.9
  • Impact factor: 4.3
A Journal of the American College of Preventive Medicine and the Association for Prevention Teaching and ResearchThe American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.For information on the American College of Preventive Medicine (ACPM) and the Association for Prevention Teaching and Research (APTR), visit their web sites at the following URLs: http://www.acpm.org/ and http://www.aptrweb.org
American Journal of Preventive Medicine

Annual Review of Fish Diseases

  • ISSN: 0959-8030
AIMS AND SCOPEAnnual Review of Fish Diseases is a peer-reviewed annual periodical which publishes current reviews and theoretical papers dealing with aquatic animal health. Of interest are reviews summarizing the current knowledge of infections of fish caused by viruses, bacteria, fungi or parasites; virulence factors of fish pathogens; nonspecific factors involved in host susceptibility and resistance to infection; the epidemiology of fish diseases, basic and applied immunology of aquatic animals, the association of pollutants with disease incidence and tumor development; and the therapy and prevention of disease.
Annual Review of Fish Diseases

Antiviral Research

  • ISSN: 0166-3542
  • 5 Year impact factor: 5
  • Impact factor: 4.5
A journal for research on the prevention and treatment of viral diseases An Official Publication of the International Society for Antiviral ResearchAntiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.new or improved vaccines against viral infections of humans;assessments of drug and vaccine safety;evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures;identification and validation of new drug targets;laboratory animal models of viral diseases;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.We encourage the submission of manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases of humans and vertebrate animals. We also publish manuscripts on the protective activity of vaccines for humans, and we will consider reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis.Note: Antiviral Research may choose not to publish certain COVID-19 papers. The COVID-19 pandemic has focused attention on the possibility that patients infected with SARS-CoV-2 might benefit from treatment with certain licensed drugs approved for conditions other than viral infection. Reports that various medications inhibit the replication of the virus in vitro have been widely publicized in news articles and on medical websites, giving the impression that compounds still in the earliest stage of evaluation may be used to prevent or treat COVID-19. Such misunderstanding may result in the inappropriate use of a drug by physicians and to self-treatment by people who obtain it from other sources, with a risk of toxicity. This may be a particular problem when a medication is available without prescription as a veterinary product. Hoarding or inappropriate use of a drug intended to treat another disease may also make it unavailable to patients with that disease. The editors of Antiviral Research may therefore choose not to publish certain COVID-19 manuscripts, when in our judgment publication is likely to result in harm, without clear evidence of benefit.The scope of AVR also includes the prevention and treatment of viral diseases of vertebrate animals. We do not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We also discourage submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."Antiviral Research is an official publication of the International Society for Antiviral Research (http://www.isar-icar.com).Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Antiviral Research

Autoimmunity Reviews

  • ISSN: 1568-9972
  • 5 Year impact factor: 9.3
  • Impact factor: 9.2
Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Autoimmunity Reviews

Biochimica et Biophysica Acta: Molecular Basis of Disease

  • ISSN: 0925-4439
  • 5 Year impact factor: 5.5
  • Impact factor: 4.2
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review.Given the complex regulation of gene expression by a vast network of miRNA's, manuscripts describing the regulation of (disease-associated) genes by single miRNAs will only be considered if they provide genuine, novel insight in a disease mechanism. Further, studies restricted to a single cell line will not be considered unless they present truly novel insights.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochimica et Biophysica Acta: Molecular Basis of Disease

Biologicals

  • ISSN: 1045-1056
  • 5 Year impact factor: 1.6
  • Impact factor: 1.5
Journal of the International Alliance for Biological StandardizationBiologicals provides a modern and multidisciplinary international forum for news, debate, and original research on all aspects of biologicals used in human and veterinary medicine. The journal publishes original papers, reviews, and letters relevant to the development, production, quality control, and standardization of biological derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern.Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.Research Areas IncludeAreas relevant to biologicals for human and veterinary use such as:• Bacterial vaccines • Blood products • Cell biology • Cell culture technology • Cellular immunology • Cytokines and allied mediators • Diagnostics • Downstream processing • Gene transfer and expression • General bacterology • General virology, endogenous and adventitious viruses • Hormones • Immunochemistry • Molecular biology • Monoclonal antibodies • Parasitology • Prion and prion disease • Protein chemistry • Toxins • Toxoids • Viral vaccines
Biologicals

Cancer Pathogenesis and Therapy

  • ISSN: 2949-7132
Cancer Pathogenesis and Therapy (CPT) is an international open access journal covering key topics in all aspects of cancer research, focusing on mechanism innovation, emerging interdisciplinary and clinical trials research in Oncology. As a Chinese Medical Association (CMA) journal, it strives to publish the highest quality content that provides authoritative guidance to oncology specialists, physicians and researchers.CPT is dedicated to publishing innovative and significant research results in basic research, translation research and clinical oncology, including novel antitumor drugs, especially clinical trials, early screening/prevention, precise diagnosis and targeted therapy, interdisciplinary oncology innovation research and clinical translation in genetics, bioinformatics, pharmacology, and biology, and also new viewpoints, new ideas, new methods and new models of cancer prevention and public health policy.CPT regularly features news and expert interviews to promote expert oncologists' views on oncology guidelines, consensus , and education.CPT is concerned about, but not limited to, the following academic scopes: Basic Cancer Research, Clinical Cancer Research, Cancer prevention and public health policy, Oncological Pharmacology, Cancer Genomics, Cancer Informatics, Drug discovery, Artificial Intelligence, etc.The article types for CPT include: Research articles, Review article, Evidence-based Oncology, Clinical Trial, Editorial, Guideline and Consensus, Study Protocols, Mini review, Perspective, Case report, technical notes, Clinical Image, Letter to Editor, etc.P-ISSN 2097-2563
Cancer Pathogenesis and Therapy